• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
NRT Smoking Cessation Aids in Germany Product Image

NRT Smoking Cessation Aids in Germany

  • Published: July 2012
  • 30 pages
  • Euromonitor International

NRT smoking cessation aids declined in Germany in 2011 for the third year in a row. Several factors continued to be responsible for this negative development in terms of retail value sales. Due to the shrinking number of smokers in Germany, the target group is getting smaller, with many consumers try to quit using alternative means (prescription drugs or herbal products for example) or not using any nicotine replacement related method at all. In addition, OTC sales could further decline, if, as...

Euromonitor International's NRT Smoking Cessation Aids in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

NRT SMOKING CESSATION AIDS IN GERMANY
Euromonitor International
July 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2006-2011
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2011
Table 5 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
Table 6 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 2 GlaxoSmithKline GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 3 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011
Competitive Positioning
Summary 4 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 5 Johnson & Johnson GmbH: Key Facts
Summary 6 Johnson & Johnson GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Johnson & Johnson GmbH: Competitive Position 2011
Novartis Consumer Health GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 8 Novartis Consumer Health GmbH: Key Facts
Summary 9 Novartis Deutschland GmbH: Operational Indicators
Company Background
Production
Summary 10 Novartis Deutschland GmbH: Production Statistics 2011
Competitive Positioning
Summary 11 Novartis Consumer Health GmbH: Competitive Position 2011
Executive Summary
Consumer Health Overall Stagnating in Germany in 2011
Market Under Pressure From Healthier Diets and More Exercise
Very Fragmented Market Continues To Be Led by Bayer Vital
Consumer Healthcare Most Often Sold in Health and Beauty Retailers
Small Decline of Consumer Health Expected Over Forecast Period in Germany
Key Trends and Developments
Ongoing Relatively Favourable Economic Conditions in Germany in 2011
Demographic Changes Continue To Influence Consumer Health in Germany
Increasing Shares of Sales Through Internet Retailing in Consumer Health
Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers
Innovation Essential for Premium Brands To Thrive in Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
Summary 12 OTC - Switches 2010-2011
Definitions
Sources
Summary 13 Research Sources

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos